Frazier Life Sciences VIII L.P. 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-06 12:40 pm Purchase | 2024-03-04 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Frazier Life Sciences VIII L.P. | 8,862,478 7.800% | 21,052 (+0.24%) | Filing |
| 2023-10-26 4:11 pm Purchase | 2023-10-24 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Frazier Life Sciences VIII L.P. | 8,841,426 9.400% | 96,108 (+1.10%) | Filing |
| 2022-08-09 3:11 pm Purchase | 2022-08-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Frazier Life Sciences VIII L.P. | 8,745,318 14.600% | 263,411 (+3.11%) | Filing |
| 2021-05-12 5:27 pm Sale | 2021-05-10 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Frazier Life Sciences VIII L.P. | 8,481,907 16.900% | -2,084,883 (-19.73%) | Filing |
| 2021-02-09 11:14 am Purchase | 2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Frazier Life Sciences VIII L.P. | 10,566,790 21.700% | 24,000 (+0.23%) | Filing |
| 2020-10-06 2:42 pm Unchanged | 2020-10-06 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Frazier Life Sciences VIII L.P. | 10,542,790 24.100% | 0 (Unchanged) | Filing |